VHL inactivation is an important pathway for the development of malignant sporadic pancreatic endocrine tumors.
about
Surgical and molecular pathology of pancreatic neoplasmsPrognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-AnalysisPathology and molecular genetics of pancreatic neoplasms.Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approachesChromosome 3p alterations in pancreatic endocrine neoplasiaProliferation rates of multiple endocrine neoplasia type 1 (MEN1)-associated tumors.Pathological and molecular evaluation of pancreatic neoplasms.Parent of origin influences the cardiac expression of vascular endothelial growth factor (Vegfa).Genetics of pancreatic neuroendocrine tumors: implications for the clinic.Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy.Sunitinib in pancreatic neuroendocrine tumors.Epigenetic regulation of hypoxia inducible factor in diseases and therapeutics.Pancreatic cancer genomes: toward molecular subtyping and novel approaches to diagnosis and therapy.Current understanding of the molecular biology of pancreatic neuroendocrine tumors.Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotype.[What is new in the pathology of pancreatic neuroendocrine tumors?].Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets
P2860
Q26748615-F9A07F2A-0BCA-4FFB-B894-F066CA71A6DEQ26749393-C21DBCD3-09EE-4215-BBB8-9D9F89014A02Q33581119-30D4AC08-82FD-4729-83A9-FEB88E4ECA49Q33835913-634963C5-2562-42B5-9A6C-FC87DE6F3D13Q34467655-A55BEABA-74DA-47D3-BA5D-FD99F878AF90Q35661980-CBD4FE92-E5C7-43C5-A415-F9FCDC367E4BQ35670143-8D8D2CC1-5080-43C7-959D-8F64DC00DBB9Q36766845-9F9405F3-02B7-4987-A6C4-6E4809F7431DQ36960581-DCAFF058-4AF6-4211-B645-E2A2E54965D0Q37981893-00414B69-0455-4959-87C6-410F91BD2031Q38015764-F1E8B1E2-1065-42E6-AA19-FB90342FBB17Q38084610-C0D6593A-A334-477C-9A81-4CE8CEE4359CQ38113752-235E329D-8403-42F1-A033-0B3368B092EDQ38120515-9A5564DE-ED54-41B7-93F4-CA5CB37725AFQ47391475-B3ED3149-263E-4A55-B3A5-F5741D5C5B4BQ53219871-A85F866E-2207-460C-B733-6B686E6ACB3FQ57816641-80A5F541-06C2-4612-8217-55658C7CB53D
P2860
VHL inactivation is an important pathway for the development of malignant sporadic pancreatic endocrine tumors.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
VHL inactivation is an importa ...... c pancreatic endocrine tumors.
@en
VHL inactivation is an importa ...... c pancreatic endocrine tumors.
@nl
type
label
VHL inactivation is an importa ...... c pancreatic endocrine tumors.
@en
VHL inactivation is an importa ...... c pancreatic endocrine tumors.
@nl
prefLabel
VHL inactivation is an importa ...... c pancreatic endocrine tumors.
@en
VHL inactivation is an importa ...... c pancreatic endocrine tumors.
@nl
P2093
P356
P1476
VHL inactivation is an importa ...... c pancreatic endocrine tumors.
@en
P2093
A M Schmitt
P Komminoth
P304
P356
10.1677/ERC-08-0297
P50
P577
2009-08-18T00:00:00Z